Login to Your Account

SkyePharma Restructures Debt as Flutiform Wins UK Approval

By Nuala Moran
Staff Writer

Wednesday, August 29, 2012

LONDON – After marathon negotiations, SkyePharma plc reached agreement on restructuring £83 million (US$131.2 million) of bond debt, avoiding the obligation to make payments – that it could not possibly have afforded – of £68.4 million in 2013 and £21.6 million in 2014.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription